Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
Abstract Hyperactivation of ABC transporter ABCB1 and induction of epithelial–mesenchymal transition (EMT) are the most common mechanism of acquired cancer chemoresistance. This study describes possible mechanisms, that might contribute to upregulation of ABCB1 and synergistically boost the acquisit...
Saved in:
Main Authors: | Raimonda Kubiliute, Indre Januskeviciene, Ruta Urbanaviciute, Kristina Daniunaite, Monika Drobniene, Valerijus Ostapenko, Rimantas Daugelavicius, Sonata Jarmalaite |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b0cfe9885eb14543aa4eed855fbd4b5b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum protein triplet TGF-β1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma
by: Rūta Urbanavičiūtė, et al.
Published: (2021) -
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
by: Mugosa Snezana, et al.
Published: (2021) -
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
by: Wang Yin, et al.
Published: (2021) -
The MDR1/ABCB1 gene rs1045642 polymorphism in colorectal cancer
by: Beata Mrozikiewicz-Rakowska, et al.
Published: (2019) -
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
by: Durgagauri H. Sabnis, et al.
Published: (2019)